(HZNP) leads the Drug Manufacturers - General industry with an overall score of 92. HZNP is up 173.83% so far this year after the company closed yesterday at $75.33. The overall score measures the company's performance based-off both short and long term indicators and means that HZNP scores better than 92% of the overall market.
Horizon Therapeutics PLC is a strong performer in the Drug Manufacturers - General industry, which has an average overall score of 52. This means that, on average, the stocks in this industry score higher than 52% of the stock market.
HZNP stock is trading down -3.37% this week following yesterday's rise. HZNP has an average analyst ranking of Strong Buy with an average price target of $104.444.